MSL
ABBV icon

Mackay Shields LLC’s AbbVie ABBV Stock Holding History

Mackay Shields LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-254,342
Closed -$41.2M – 249
2022
Q1 		$41.2M Sell
254,342
-9,988
-4% -$1.45M 0.36% 65
2021
Q4 		$35.8M Sell
264,330
-6,058
-2% -$716K 0.3% 86
2021
Q3 		$29.2M Sell
270,388
-7,816
-3% -$893K 0.27% 93
2021
Q2 		$31.3M Sell
278,204
-106,918
-28% -$12M 0.29% 84
2021
Q1 		$41.7M Sell
385,122
-46,375
-11% -$4.96M 0.3% 58
2020
Q4 		$46.2M Sell
431,497
-60,470
-12% -$5.81M 0.32% 49
2020
Q3 		$43.1M Sell
491,967
-146,081
-23% -$13.8M 0.29% 54
2020
Q2 		$62.6M Buy
638,048
+97,131
+18% +$8.55M 0.5% 28
2020
Q1 		$41.2M Sell
540,917
-106,815
-16% -$9.1M 0.38% 42
2019
Q4 		$57.4M Buy
647,732
+81,120
+14% +$6.73M 0.4% 36
2019
Q3 		$42.9M Sell
566,612
-140,488
-20% -$9.63M 0.26% 90
2019
Q2 		$51.4M Buy
707,100
+29,910
+4% +$2.35M 0.35% 53
2019
Q1 		$54.6M Buy
677,190
+77,825
+13% +$6.37M 0.4% 40
2018
Q4 		$55.3M Sell
599,365
-4,399
-0.7% -$387K 0.45% 34
2018
Q3 		$57.1M Buy
603,764
+86,867
+17% +$8.24M 0.44% 40
2018
Q2 		$47.9M Sell
516,897
-215,710
-29% -$21.1M 0.33% 59
2018
Q1 		$69.3M Buy
+732,607
New +$80.5M 0.43% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackay Shields LLC's ABBV Position: Q2 2022 in Review

Mackay Shields LLC sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 254,342 shares — an estimated $41.2M sold.

Mackay Shields LLC first reported a position in ABBV in Q1 2018 and held it in 17 quarters. The position peaked at $69.3M in Q1 2018. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Mackay Shields LLC reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 254,342 AbbVie shares in Q2 2022, an estimated $41.2M.
  • Mackay Shields LLC first reported a position in AbbVie in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's AbbVie position peaked at $69.3M in Q1 2018.
  • 3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.